Risk factors for lymphatic and hematogenous metastasis after diagnosis of cutaneous Melanoma in Taiwan
Copyright © 2022 Formosan Medical Association. Published by Elsevier B.V. All rights reserved..
BACKGROUND: Risk factors of lymphatic and hematogenous metastasis in cutaneous melanoma remained unclear in Asian population. This study aimed to identify clinical and histopathological factors to predict metastatic pathways in cutaneous melanoma in Taiwan.
METHODS: A total of 247 patients diagnosed as stage I and II melanoma, followed at National Taiwan University Hospital were included in this retrospective study from 1980 to 2020. Kaplan-Meier curves and Cox proportional hazards regression were utilized to identify risk factors.
RESULTS: During a median follow-up of 143 months, 48 (19.4%) and 62 (25.1%) patients developed lymphatic and hematogenous metastasis respectively. In the univariate analysis, age> 70 years, greater Breslow thickness, ulceration, neurotropism, and NRAS mutation were significant risk factors for lymphatic metastasis in all subtypes of melanoma. Age >70 years, head and neck location, thickness, ulceration, higher mitotic rate, neurotropism, and NRAS mutation were significant predictors of hematogenous metastasis in all subtypes. In the multivariate analysis, greater thickness (HR for 2.0-4.0 mm, 4.5; p = .009 and HR for >4.0 mm, 5.7; p = .003) retained its significance as an independent risk factor for lymphatic metastasis in all subtypes of melanoma. Thickness (HR for >4.0 mm, 5.7; p < .001) and ulceration (HR, 2.5; p = .001) were independent risk factors for hematogenous metastasis.
CONCLUSION: Risk factors of metastasis not only differ between lymphatic and hematogenous pathways, but also differ between ethnics and melanoma subtypes. Better understanding the behavior of cutaneous melanoma may help guide further treatments and follow-up plans.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:121 |
---|---|
Enthalten in: |
Journal of the Formosan Medical Association = Taiwan yi zhi - 121(2022), 9 vom: 15. Sept., Seite 1823-1831 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hsu, Che-Chia [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acral melanoma |
---|
Anmerkungen: |
Date Completed 30.08.2022 Date Revised 13.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jfma.2022.02.018 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM338228705 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM338228705 | ||
003 | DE-627 | ||
005 | 20231227130732.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jfma.2022.02.018 |2 doi | |
028 | 5 | 2 | |a pubmed24n1225.xml |
035 | |a (DE-627)NLM338228705 | ||
035 | |a (NLM)35292188 | ||
035 | |a (PII)S0929-6646(22)00099-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hsu, Che-Chia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Risk factors for lymphatic and hematogenous metastasis after diagnosis of cutaneous Melanoma in Taiwan |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.08.2022 | ||
500 | |a Date Revised 13.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Formosan Medical Association. Published by Elsevier B.V. All rights reserved. | ||
520 | |a BACKGROUND: Risk factors of lymphatic and hematogenous metastasis in cutaneous melanoma remained unclear in Asian population. This study aimed to identify clinical and histopathological factors to predict metastatic pathways in cutaneous melanoma in Taiwan | ||
520 | |a METHODS: A total of 247 patients diagnosed as stage I and II melanoma, followed at National Taiwan University Hospital were included in this retrospective study from 1980 to 2020. Kaplan-Meier curves and Cox proportional hazards regression were utilized to identify risk factors | ||
520 | |a RESULTS: During a median follow-up of 143 months, 48 (19.4%) and 62 (25.1%) patients developed lymphatic and hematogenous metastasis respectively. In the univariate analysis, age> 70 years, greater Breslow thickness, ulceration, neurotropism, and NRAS mutation were significant risk factors for lymphatic metastasis in all subtypes of melanoma. Age >70 years, head and neck location, thickness, ulceration, higher mitotic rate, neurotropism, and NRAS mutation were significant predictors of hematogenous metastasis in all subtypes. In the multivariate analysis, greater thickness (HR for 2.0-4.0 mm, 4.5; p = .009 and HR for >4.0 mm, 5.7; p = .003) retained its significance as an independent risk factor for lymphatic metastasis in all subtypes of melanoma. Thickness (HR for >4.0 mm, 5.7; p < .001) and ulceration (HR, 2.5; p = .001) were independent risk factors for hematogenous metastasis | ||
520 | |a CONCLUSION: Risk factors of metastasis not only differ between lymphatic and hematogenous pathways, but also differ between ethnics and melanoma subtypes. Better understanding the behavior of cutaneous melanoma may help guide further treatments and follow-up plans | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Acral melanoma | |
650 | 4 | |a Hematogenous | |
650 | 4 | |a Lymphatic | |
650 | 4 | |a Metastasis | |
650 | 4 | |a Risk factor | |
700 | 1 | |a Lee, Tung-Lin |e verfasserin |4 aut | |
700 | 1 | |a Lin, Ming-Hsien |e verfasserin |4 aut | |
700 | 1 | |a Liao, Yi-Hua |e verfasserin |4 aut | |
700 | 1 | |a Liau, Jau-Yu |e verfasserin |4 aut | |
700 | 1 | |a Sheen, Yi-Shuan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the Formosan Medical Association = Taiwan yi zhi |d 1992 |g 121(2022), 9 vom: 15. Sept., Seite 1823-1831 |w (DE-627)NLM012627941 |x 0929-6646 |7 nnns |
773 | 1 | 8 | |g volume:121 |g year:2022 |g number:9 |g day:15 |g month:09 |g pages:1823-1831 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jfma.2022.02.018 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 121 |j 2022 |e 9 |b 15 |c 09 |h 1823-1831 |